Literature DB >> 16234763

[Effect of nebivolol on parameters of cerebral haemodynamics and 24-hour blood pressure profile in patients with arterial hypertension].

L I Gapon, A A Prilepova, M D Tsygol'nik.   

Abstract

AIM: To elucidate effect of nebivolol on parameters of cerebral hemodynamics and 24-hour blood pressure (BP) profile in patients with hypertension.
MATERIAL AND METHODS: Patients with hypertension of 2nd degree (n=55, age 35-50 years) were divided into 2 groups with similar age, sex, duration of hypertension, and office BP level. Thirty one patients received nebivolol (5-7.5 mg/day), 24 -- atenolol (75-100 mg/day) for 8 weeks.
RESULTS: Nebivolol affected positively 24-hour BP profile (decreased variability and morning increase of BP), improved parameters of cerebral hemodynamics (increased index of cerebrovascular reactivity which reflected the state of adaptation of cerebral arteries). Atenolol exerted similar antihypertensive action but did not alter variability and morning increase of BP. Effect of atenolol on cerebral hemodynamics comprised increases of cerebrovascular reactivity index and vasoconstriction reserve.
CONCLUSION: Compared with atenolol nebivolol exerts more favorable effect on 24-hour BP profile and improves cerebral hemodynamics at the account of increased vasodilatation reserve.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16234763

Source DB:  PubMed          Journal:  Kardiologiia        ISSN: 0022-9040            Impact factor:   0.395


  2 in total

Review 1.  Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease.

Authors:  Hirofumi Tomiyama; Akira Yamashina
Journal:  Int J Hypertens       Date:  2014-01-30       Impact factor: 2.420

2.  Impact of Early Intravenous Haemostatic Drugs on Brain Haemorrhage Patients and Their Image Segmentation Based on RGB-D Images.

Authors:  Zhenzhen Wang; Yating Mou; Hao Li; Rui Yang; Yanxun Jia
Journal:  J Healthc Eng       Date:  2022-01-07       Impact factor: 2.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.